As we step into 2026, the healthcare private equity landscape is defined by both powerful momentum and meaningful constraints. Record levels of dry powder and a growing pipeline of high‑quality assets suggest increased deal...more
1/13/2026
/ ACOs ,
Acquisition Agreements ,
Artificial Intelligence ,
Corporate Practice of Medicine ,
EBITDA ,
Financing ,
Food and Drug Administration (FDA) ,
Hart-Scott-Rodino Act ,
Health Care Providers ,
Healthcare Facilities ,
Interest Rates ,
Investment ,
Investment Funds ,
Investors ,
Machine Learning ,
Merger Agreements ,
Pharmaceutical Industry ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Value-Based Care
On January 2, the Small Business Administration (SBA) published a final rule to implement its Notice of Proposed Rulemaking from July 7, 2025 that was intended to remove regulations that are “obsolete, inefficient, or...more
1/9/2026
/ Deregulation ,
Executive Orders ,
Federal Funding ,
Final Rules ,
Government Agencies ,
Investment Funds ,
Investment Management ,
Mining ,
National Security ,
Notice of Proposed Rulemaking (NOPR) ,
Private Equity ,
Regulatory Reform ,
Regulatory Requirements ,
Rulemaking Process ,
SBA ,
SBA Lending Programs ,
SBIC ,
Small Business ,
Technology Sector
Bass, Berry & Sims hosted the 15th annual Health Care Investors Conference (HCIC), co-sponsored by Deloitte, Gallagher and Houlihan Lokey, on October 29. Each year HCIC brings together hundreds of leading health care industry...more
11/13/2025
/ Artificial Intelligence ,
Digital Health ,
Due Diligence ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Home Health Agencies ,
Home Health Care ,
Hospice ,
Investment ,
Investors ,
Medicaid ,
Medicare ,
Mental Health ,
Popular ,
Private Equity ,
Private Equity Firms ,
Value-Based Payments
W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity. As we begin 2024, we have highlighted the issues and trends that...more
1/9/2024
/ Acquisitions ,
Artificial Intelligence ,
Corporate Transparency Act ,
Department of Justice (DOJ) ,
Diversity ,
Equity Markets ,
FinCEN ,
Funding ,
Healthcare ,
Investment ,
Investors ,
Mergers ,
Non-Compete Agreements ,
Pharmaceutical Industry ,
Popular ,
Privacy Laws ,
Private Equity ,
Reporting Requirements ,
Restrictive Covenants ,
Risk Management ,
Safe Harbors ,
Section 340B ,
Self-Disclosure Requirements ,
Value-Based Care
In the wake of several high-profile bank failures over the past week and the turmoil surrounding the larger banking industry in general, it is important to review the permissible uses of idle funds (i.e., funds not actively...more
As we kick off 2023, we are optimistic that the healthcare private equity (PE) market will be resilient despite various headwinds. As you think ahead, please consider the issues and trends summarized below that may be helpful...more
1/9/2023
/ Capital Markets ,
Cyber Attacks ,
Cybersecurity ,
Debt Market ,
Earn-Outs ,
Employee Retention ,
Environmental Social & Governance (ESG) ,
Health Care Providers ,
Healthcare ,
Healthcare Fraud ,
Investment ,
Investors ,
Minority Equity Investments ,
New Legislation ,
New Rules ,
Non-Compete Agreements ,
Physicians ,
Private Equity ,
Proposed Regulation ,
Ransomware ,
Rollover Equity ,
Section 220 Request
On November 17, 2022, the U.S. Small Business Administration (SBA) published an interim final rule in the Federal Register to make certain inflationary adjustments for the alternative size standards under the Small Business...more
On October 19, the U.S. Small Business Administration (SBA) published proposed rules in the Federal Register to significantly amend the regulations governing the Small Business Investment Company (SBIC) program. The proposal,...more